NCT03004612View on ClinicalTrials.gov

Effect of Linagliptin + Metformin vs Metformin Alone in Patients With Prediabetes

PHASE4CompletedINTERVENTIONAL
Enrollment

144

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

May 31, 2019

Study Completion Date

June 30, 2019

Conditions
Prediabetic StateInsulin Resistance
Interventions
COMBINATION_PRODUCT

Linagliptin + metformin

Linagliptin-Metformin 2.5/850mg twice daily plus a lifestyle modification program based on nutritional assesment, physical activity prescription and general counseling

DRUG

Metformin

Metformin 850mg twice daily plus a lifestyle modification program based on nutritional assesment, physical activity prescription and general counseling

Trial Locations (1)

37670

Universidad de Guanajuato, León

All Listed Sponsors
collaborator

Hospital Regional de Alta Especialidad del Bajio

OTHER

lead

Universidad de Guanajuato

OTHER

NCT03004612 - Effect of Linagliptin + Metformin vs Metformin Alone in Patients With Prediabetes | Biotech Hunter | Biotech Hunter